2015
DOI: 10.1016/j.jss.2015.01.033
|View full text |Cite
|
Sign up to set email alerts
|

Effect of adenosine triphosphate-sensitive potassium activation on peripheral and central pain sensitization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Unfortunately, most studies have not closely investigated which K ATP channel subunits are contributing to the analgesic effects of these treatments or where these K ATP channels are located (e.g., spinal cord versus peripheral nervous system). Previous data suggest that Kir6.2/SUR1 is the predominant functional subtype within the peripheral nervous system but pain sensitization appears to be mediated mostly by SUR2 after cutaneous injury [9,10,11,12,13,14]. Current data are also lacking on K ATP channel expression changes occurring after initiation of chronic pain in the peripheral versus central nervous system over an extended (>30 days) period of time.…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, most studies have not closely investigated which K ATP channel subunits are contributing to the analgesic effects of these treatments or where these K ATP channels are located (e.g., spinal cord versus peripheral nervous system). Previous data suggest that Kir6.2/SUR1 is the predominant functional subtype within the peripheral nervous system but pain sensitization appears to be mediated mostly by SUR2 after cutaneous injury [9,10,11,12,13,14]. Current data are also lacking on K ATP channel expression changes occurring after initiation of chronic pain in the peripheral versus central nervous system over an extended (>30 days) period of time.…”
Section: Introductionmentioning
confidence: 99%
“…agonists can significantly reduce postoperative pain in rats by inhibiting the apoptosis of vascular endothelial cells around the incision (10,11). The KaTP activator nicorandil is a nitric oxide donor approved for the treatment of patients with angina pectoris, which also exhibits activities in models of inflammatory and nociceptive pain (12,13).…”
Section: Discussionmentioning
confidence: 99%
“…our previous studies have shown that adenosine triphosphate-sensitive potassium channel (KaTP) agonists may relieve postoperative pain in rats by inhibiting the apoptosis of vascular endothelial cells (10,11). KaTP agonists can inhibit touch-induced pain in a dose-dependent manner (11).…”
Section: Introductionmentioning
confidence: 99%